FR2181778A1 - - Google Patents

Info

Publication number
FR2181778A1
FR2181778A1 FR7307334A FR7307334A FR2181778A1 FR 2181778 A1 FR2181778 A1 FR 2181778A1 FR 7307334 A FR7307334 A FR 7307334A FR 7307334 A FR7307334 A FR 7307334A FR 2181778 A1 FR2181778 A1 FR 2181778A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7307334A
Other versions
FR2181778B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19722209835 external-priority patent/DE2209835C3/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2181778A1 publication Critical patent/FR2181778A1/fr
Application granted granted Critical
Publication of FR2181778B1 publication Critical patent/FR2181778B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7307334A 1972-03-01 1973-03-01 Expired FR2181778B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722209835 DE2209835C3 (de) 1972-03-01 Insulinderivate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2181778A1 true FR2181778A1 (fr) 1973-12-07
FR2181778B1 FR2181778B1 (fr) 1976-12-03

Family

ID=5837578

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7307334A Expired FR2181778B1 (fr) 1972-03-01 1973-03-01

Country Status (11)

Country Link
US (1) US3907763A (fr)
JP (1) JPS4897889A (fr)
AT (1) AT333987B (fr)
BE (1) BE795997A (fr)
CH (1) CH579916A5 (fr)
DK (1) DK146623C (fr)
FR (1) FR2181778B1 (fr)
GB (1) GB1374385A (fr)
IL (1) IL41615A (fr)
NL (1) NL7302898A (fr)
SE (1) SE421690B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2283124A1 (fr) * 1974-08-16 1976-03-26 Hoechst Ag Procede de preparation d'insuline, de ses analogues et derives

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428412A1 (de) * 1974-06-12 1976-01-15 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
USRE32015E (en) * 1974-06-12 1985-10-29 Hoechst Aktiengesellschaft Process for the manufacture of insulin, analogs and derivatives thereof
US6869930B1 (en) * 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
UA45321C2 (uk) * 1993-09-17 2002-04-15 Ново Нордіск А/С Похідне інсуліну, фармацевтична композиція для лікування діабету та спосіб лікування діабету
US20010041786A1 (en) * 1995-06-07 2001-11-15 Mark L. Brader Stabilized acylated insulin formulations
US5898067A (en) * 1997-02-07 1999-04-27 Novo Nordisk A/S Crystallization of proteins
KR20010024556A (ko) 1997-10-24 2001-03-26 피터 지. 스트링거 불용성 인슐린 조성물
US6531448B1 (en) 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
US6323311B1 (en) 1999-09-22 2001-11-27 University Of Utah Research Foundation Synthesis of insulin derivatives
WO2011031662A1 (fr) 2009-09-08 2011-03-17 Kent Stephen B H Insuline à liaison ester
WO2011146973A1 (fr) * 2010-05-25 2011-12-01 Monash University Analogues de l'insuline
WO1990007280A1 (fr) * 2010-07-13 1990-07-12 Victor Manuel Pracas Dispositif de stockage et de distribution de confiserie
SG10201809457YA (en) 2014-11-21 2018-11-29 Merck Sharp & Dohme Insulin receptor partial agonists
US11058775B2 (en) 2016-04-26 2021-07-13 Merck Sharp & Dohme Corp. Insulin dimer-incretin conjugates
EP3463429A4 (fr) 2016-05-24 2020-07-22 Merck Sharp & Dohme Corp. Agonistes partiels du récepteur de l'insuline et analogues du glp-1
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2123524A1 (en) * 1971-01-28 1972-09-08 Nat Res Dev N-blocked insulin derivs - with high water solubility, and the corresp o-blocked cpds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679653A (en) * 1968-09-27 1972-07-25 Monsanto Co Hormonally-active reaction product of a polymer with a hormone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2123524A1 (en) * 1971-01-28 1972-09-08 Nat Res Dev N-blocked insulin derivs - with high water solubility, and the corresp o-blocked cpds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2283124A1 (fr) * 1974-08-16 1976-03-26 Hoechst Ag Procede de preparation d'insuline, de ses analogues et derives

Also Published As

Publication number Publication date
SE421690B (sv) 1982-01-25
DK146623B (da) 1983-11-21
ATA184873A (de) 1976-04-15
NL7302898A (fr) 1973-09-04
AT333987B (de) 1976-12-27
US3907763A (en) 1975-09-23
IL41615A0 (en) 1973-04-30
FR2181778B1 (fr) 1976-12-03
GB1374385A (en) 1974-11-20
IL41615A (en) 1975-12-31
CH579916A5 (fr) 1976-09-30
DE2209835A1 (de) 1973-09-06
BE795997A (fr) 1973-08-27
DK146623C (da) 1984-04-30
DE2209835B2 (de) 1976-04-29
JPS4897889A (fr) 1973-12-13

Similar Documents

Publication Publication Date Title
FR2176756A1 (fr)
FR2181778B1 (fr)
JPS5650145B2 (fr)
FR2212637B1 (fr)
JPS4950226A (fr)
USB521600I5 (fr)
JPS4915298A (fr)
JPS4956962A (fr)
JPS49100322U (fr)
FR2208956A1 (fr)
JPS4982142U (fr)
JPS5219063Y2 (fr)
JPS5218456Y2 (fr)
JPS5626533B2 (fr)
JPS49103789U (fr)
JPS4987330A (fr)
JPS4918592U (fr)
JPS4919036U (fr)
JPS4880841A (fr)
CH545744A (fr)
CH571648A5 (fr)
BG18353A1 (fr)
BG18294A1 (fr)
BG18254A1 (fr)
CH559322A5 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse